lomustine has been researched along with Hemolysis in 1 studies
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The selected LNL showed improved pharmacokinetic profile both in blood and brain in the experimental mice models along with negligible hemolysis in mice blood cells." | 5.62 | Lomustine Incorporated Lipid Nanostructures Demonstrated Preferential Anticancer Properties in C6 Glioma Cell Lines with Enhanced Pharmacokinetic Profile in Mice. ( Barik, B; Kumar, LA; Pattnaik, G; Satapathy, BS, 2021) |
| " The selected LNL showed improved pharmacokinetic profile both in blood and brain in the experimental mice models along with negligible hemolysis in mice blood cells." | 1.62 | Lomustine Incorporated Lipid Nanostructures Demonstrated Preferential Anticancer Properties in C6 Glioma Cell Lines with Enhanced Pharmacokinetic Profile in Mice. ( Barik, B; Kumar, LA; Pattnaik, G; Satapathy, BS, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satapathy, BS | 1 |
| Kumar, LA | 1 |
| Pattnaik, G | 1 |
| Barik, B | 1 |
1 other study available for lomustine and Hemolysis
| Article | Year |
|---|---|
Lomustine Incorporated Lipid Nanostructures Demonstrated Preferential Anticancer Properties in C6 Glioma Cell Lines with Enhanced Pharmacokinetic Profile in Mice.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Brain; Cell Line, Tumor; Cell Survival; Dru | 2021 |